IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Solvay Raises Offer for Biotech Firm

9:03 AM MDT | July 9, 2008 | Kerri Walsh

Solvay says it has increased its offer to acquire biotechnological firm Innogenetics (Gent, Belgium) from €5.75/share in cash, to €6.50/share in cash. The higher offer values the deal at €200.7 million for all of the outstanding shares, Solvay says. This is a 74% premium to the closing price of April 24, 2008, the day before Solvay’s initial offer. Solvay says it raised its offer price following a €215-million bid for Innogenetics from Gen-Probe (San Diego) in June. The deal between Solvay and Inogenetics is expected to close during...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa